Weizman et al. [62] suggested that tumour infiltrating macrophages were responsible for stimulating the upregulation of CDA and acquisition of chemoresistance against gemcitabine in pancreatic cancer cells. The gene discussed is CDA; the disease is familial pancreatic carcinoma.